beta-Thalassemia.
Origa R.
Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3.
Beta-thalassemia.
Galanello R, Origa R.
Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11.
Thalassemia.
Aydinok Y.
Hematology. 2012 Apr;17 Suppl 1:S28-31. doi: 10.1179/102453312X13336169155295.
Thalassemia Minor and Major: Current Management.
Choudhry VP.
Indian J Pediatr. 2017 Aug;84(8):607-611. doi: 10.1007/s12098-017-2325-1. Epub 2017 Apr 24.
Endocrinopathies in beta thalassemia: a narrative review.
Venou TM, Barmpageorgopoulou F, Peppa M, Vlachaki E.
Hormones (Athens). 2024 Jun;23(2):205-216. doi: 10.1007/s42000-023-00515-w. Epub 2023 Dec 16.
Beta-thalassaemia.
Thein SL.
Baillieres Clin Haematol. 1998 Mar;11(1):91-126. doi: 10.1016/s0950-3536(98)80071-1.
Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation.
Chauhan W, Shoaib S, Fatma R, Zaka-Ur-Rab Z, Afzal M.
Br J Clin Pharmacol. 2022 Aug;88(8):3610-3626. doi: 10.1111/bcp.15343. Epub 2022 Apr 18.
Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
Sheth S, Taher AT, Coates TD, Kattamis A, Cappellini MD.
Br J Haematol. 2023 Jun;201(5):824-831. doi: 10.1111/bjh.18801. Epub 2023 Apr 10.
Novel therapies in beta-thalassaemia.
Grech L, Borg K, Borg J.
Br J Clin Pharmacol. 2022 Jun;88(6):2509-2524. doi: 10.1111/bcp.14918. Epub 2021 Jun 4.
Thalassemia intermedia.
Camaschella C, Cappellini MD.
Haematologica. 1995 Jan-Feb;80(1):58-68.
